COVID-19 vaccines
By Paul Burkhardt and BloombergDecember 2, 2021
By Christiaan HetznerDecember 2, 2021
MagazineModerna’s COVID vaccine success made the stock a big pandemic winner. Will the run continue?
By Rey MashayekhiDecember 2, 2021
CommentaryIf we want the pandemic to end, CEOs need to do what governments won’t—including getting tougher and smarter about vaccines
By Mark Dybul and Serhat GümrükçüDecember 1, 2021
PoliticsEurope is hitting the unvaccinated with fines, lockdowns, and mandates. Could America be next?
By Sophie MellorDecember 1, 2021
By David MeyerDecember 1, 2021
HealthWhy COVID pills are likely to maintain efficacy against the Omicron COVID variant—even if vaccines don’t
By Grady McGregorDecember 1, 2021
By Erika Fry and Nicolas RappNovember 30, 2021
By Kylie LoganNovember 30, 2021
NewslettersBeware knee-jerk reactions to Omicron, as there is so much we don’t yet know about the new COVID-19 variant
By David MeyerNovember 30, 2021
By Bernhard WarnerNovember 30, 2021
HealthModerna’s CEO believes new COVID vaccines are likely needed to protect against the Omicron variant
By Michelle Fay Cortez and BloombergNovember 30, 2021
HealthBiden says Omicron demands that countries share vaccines as China donates 1 billion doses to Africa
By Grady McGregorNovember 30, 2021
By Marco Quiroz-GutierrezNovember 29, 2021
Most Popular
